Prophylactic Oophorectomy

Slides:



Advertisements
Similar presentations
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Advertisements

Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Epidemiology of Gynaecological Cancers. General Overview On global basis cervical cancer is the most common pelvic malignancy in developing countries.
Breast & Ovarian Cancer: BRCA1 and BRCA2
Breast Cancer Risk and Risk Assessment Models
SURVIVORS TEACHING STUDENTS: SAVING WOMEN’S LIVES®
Type Of Cancer:Location: CarcinomaEpithelial Cells SarcomaConnective Tissue LeukemiaCirculatory / Lymphatic.
Max Brinsmead MB BS PhD May 2015
IS HRT SAFE? Rosol Hamid Consultant O&G. NO What is safe? Driving Swimming Crossing the street Cycling Riding a motor bike Parachute jumping Flying.
Endometrial Cancer Nancy Wozniak, MD.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Chapter 61 Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 1.
Ovary.
22/10/1436. Addar Professor Gyneoncologist OB/GYN Dept. KKUH and College of Medicine MKing Saud University.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Hysterectomy.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Eleni Galani Medical Oncologist
SUMAYYA EBRAHIM GYNAECOLOGIST PARKLANE CLINIC JOHANNESBURG
Ovarian Cancer National Alliance Ovarian Cancer: What All Women Need to Know.
Integrated Cancer Screening Education Modules.  A disease that starts in the cells  Genes inside cells order growth, work, reproduction and death What.
Dr Matt Hewitt Prophylactic Bilateral Salpingoophorectomy.
Fallopian Tube and Ovarian Malignancy Schwartz's Principles of Surgery Chapter 41. Gynecology.
Ovarian Cancer Research in Allied Health Erin Brewer.
Hysterectomy for Undergraduates
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
Endometrial Carcinoma
Breast/ovary.  A 32-year-old Caucasian female presents to your office with a breast mass found to be malignant on biopsy. Ten years ago, she was diagnosed.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
Personal Risk Factors Gender being a woman is the main risk factor for developing breast cancer (100 times more common in women) Age occurrence increase.
BRCA1 and BRCA2 are genes which normally help to prevent breast cancer by making proteins which inhibit abnormal cellular growth. While a woman with an.
Breast Ovarian Hereditary Breast & Ovarian Cancer Knowing one’s family medical history can be life-saving.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Tamoxifen associated changes
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Laparoscopic supracervical hysterectomy and total laparoscopic hysterectomy: A comparison of peri- operative outcomes Dr Kate Maclaran, Mr Nilesh Agarwal,
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Dr. Ahmed jasim Ass.Prof.MBChB-DOG-FICMS COSULTANT OF GYN. & OBST. COSULTANT OF GYN. & OBST.
The Elliott Breast Center * Baton Rouge, LA *
Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
Gynecologic Oncology New or Old subspecialty Samir Fouad Khalaf Professor OBGYN Al-Azhar University President
Ovarian Cancer aka “The disease that whispers” Statistics The average age when ovarian cancer is detected in women is 56.3 years. Less than 1 out of.
M.D. Browning, M.D. ‘77.  Most Common Cancer of Female Reproductive System  60,000/year with 10,000 deaths  Normal Cells in the Endometrium.
Pathways involved in hereditary breast cancer
SURGICAL ONCOLOGY AND TUMOR MARKERS
Screening for Ovarian Cancer
Endometrial hyperplasia
Post Menopausal Bleeding
Diagnosis and clinical manifestation
Endometrial cancer on the rise in older women (August 2014)
The long-term effect of endometrioma surgery on ovarian reserve:
OVARIAN CANCER qpt
Male and Female Reproductive Health Concerns
Survivors Teaching Students: Saving Women’s LivesSM
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
Breast Screening and Risk Assessment
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Chapter 61 Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 1.
Hysterectomy Hysterectomy is the surgical removal of the uterus. It is the second most common type of major surgery performed on women of childbearing.
Female Sexual Anatomy and Physiology
Management of Endometrial Hyperplasia D Hind Showman
AGC&AIS Setareh Akhavan M.D Gynecologist Oncologist
Adnexal masses 5 cm in diameter or greater extirpated during cesarean operation Serenat Eris Yalcin1, Yakup Yalcin2, Mehmet Ozgur Akkurt1, And Yavuz1,
ENDOMETRIAL CARCINOMA
Practical histopathology
Presentation transcript:

Prophylactic Oophorectomy Presented by Dr. AHMED WALID ANWAR Lecturer of Obstetrics and Gynecology Benha Faculty of Medicine Egypt 2008

Ovarian Physiology The ovary has two main functions: 1-Reproductive function: produce ♀ gametes. 2-Endocrinal and metabolic function: produce hormones.

Ovarian Physiology The ovary is a complex metabolic organ consisting of Follicular and stromal compartments. 1-Follicles: produce both androgens and estrogen. 2-Stromal tissue: synthesizes androgens.

Ovarian steroidogenesis

Ovarian Physiology With the loss of all follicles around menopause, both androgen and estrogen levels decrease.

But the ovary remains a source of postmenopausal androgens that are peripherally converted to estrogen.

Ovarian Physiology The positive effects of estrogen production on lipid metabolism and bone remodeling remain the primary argument for retention of the ovaries in premenopausal women.

Ovarian Physiology The benefits of estrogen are well documented , but any benefits of ovarian androgen production remain to be documented . The role of endogenous androgens and the consequences of their removal may be significant but have not yet been clarified.

Prophylactic Oophorectomy Def: Prophylactic oophorectomy is the removal of the ovaries for the potential benefit of preventing long-term morbidity and mortality. N.B: The term prophylactic implies that the ovaries are normal at the time of removal.

Incidental oophorectomy : Def: is a term commonly used when the ovaries are removed at the time of another indicated surgery, and this term should not be used interchangeably with prophylactic oophorectomy. N.B: The term incidental implies that the surgery occurs by chance or without consequence.

Oophorectomy can be performed either: 1- Alone as a planned surgical procedure or 2- In conjunction with other planned surgical procedures such as hysterectomy or colectomy

Incidence of Prophylactic Oophorectomy The literature has recorded elective oophorectomy rates of between 50% and 66% in women 40-64 years of age undergoing hysterectomy . Data from the Centers for Disease Control and Prevention collected between 1988 and 1993 concur that ovarian retention occurs in approximately 40-50% of patients undergoing hysterectomy at 40 years of age or older.

Indications Of Prophylactic Oophorectomy 1- Female with Dysgenetic gonads <30yrs old with Y chromosome. 2- Patient with hereditary nonpolypsis colorectal cancer. 3- Old patient during pelvic or general abdominal surgery???.

Indications Of Prophylactic Oophorectomy 4- Some cases of breast cancer. 5- Malignant tumor of FGT, If one ovary has malignancy and the other is normal, in old age or in patient with complete family. 6- Patient with BRCA1, BRCA2 mutations.

Indications Of Prophylactic Oophorectomy BRCA1, BRCA2 are tumor suppressor genes present in chromosome No 17,13,respectively. They encodes protein necessary for DNA repair. Any mutation →Uncontrolled cell growth →cancer in Breast, Ovary ,Tube and/or Peritoneum.

BRCA1 mutation carrier BRCA2 mutation carrier Risk of breast cancer 20-60% 10-20% Risk of ovarian cancer 20-40% Age of onset Late 30th ,early 40th yrs 59 yrs

Timing of Prophylactic Oophorectomy 1-The current thinking in UK is to : Discuss Oophorectomy in ♀>40yrs . Recommend it in ♀>45yrs . Majority of gynecologists recommend removal of ovaries at time of hysterectomy around menopause.

Timing of Prophylactic Oophorectomy 2- In high risk patient Oophorectomy must be done {depending on possible age of development of malignancy}: BRCA1 carrier mutation: surgery at 35yrs old or when family is completed. BRCA2 carrier mutation: surgery is delayed to near menopause.

What to be removed during Prophylactic Oophorectomy? Risk Reducing Surgery in high risk patients.

Peritoneal washing cytology + Random Peritoneal + omental biopsies+ At minimum: BSO+ Peritoneal washing cytology + Random Peritoneal + omental biopsies+ Sectioning tubes and ovaries for histopathological examination. At maximum: Hysterectomy is performed in addition .

Value Of Hysterectomy 1-↓Risk of tubal cancer {No residual fallopian tube}. 2-↓Risk of uterine cancer due to : Hyperestrogenic state. Tamoxafen used for treatment of breast cancer. 2-↓Risk of uterine papillary serous carcinoma that may be correlated with BRCA1 mutations.

Some authors suggested that removal of the uterus without ovaries may reduce risk of ovarian cancer why? 1-Surgical procedure allow surgeon to screen for malignancy. 2-Alteration of blood supply to ovaries. 3-No ascent of carcinogens from vagina.

Risks And Benefits of Prophylactic Oophorectomy

Benefits of Prophylactic Oophorectomy 1- ↓risk of development of cancer, ovary, tube, and peritoneal cancer in BRCA mutation carrier. N.B: It has been suggested that, in the USA, approximately 1,000 cases of ovarian cancer can be prevented if prophylactic oophorectomy is practiced in all women older than 40 years of age who undergo hysterectomy.

Benefits of Prophylactic Oophorectomy 2- ↓ risk of cancer breast, why? By removing the source of endogenous E {↓TO21% compared to 42% in women not undergo surgery}. N.B: Also, it improves survival in women with diagnosed breast cancer

Risks Of Prophylactic Oophorectomy 1} Surgical Risk . 2} Risk of malignancy. 3} Risk Premature menopause.

1}Surgical Risk : Depends on: 1- Skill of surgeon. 2- Patient general conditions. 3- Route of surgery: - Laparoscopic surgery → 1.9% - Open surgery →4 -5%

1}Surgical Risk : 4 -Type of surgery: There are no studies evaluating increased operative risk or morbidity when prophylactic oophorectomy is included at the time of abdominal hysterectomy. Retrospective studies looking when prophylactic oophorectomy is included at the time of vaginal hysterectomy have shown that the ovaries can be removed successfully in 65-97% of patients .

1}Surgical Risk : One study found no significant increase in operating time, estimated blood loss, length of hospital stay, or postoperative morbidity between patients who had their ovaries removed and those who did not . Another study found that oophorectomy added 23.4 minutes to the total operating time compared with vaginal hysterectomy alone .

2} Risk of malignancy. Oophorectomy does not eliminate the risk of cancer completely (patients still can develop peritoneal carcinoma, which acts like ovarian cancer), reported cases are rare (1-2%).

3} Risk Of Premature menopause. Prophylactic Oophorectomy is complicated by Premature menopausal symptoms . HRT { Yes or, No} → Controversies

HRT { Yes or, No} BRCA1 mutation carrier →more E&P –ve receptors. So BRCA1 mutation carrier may not be at ↑ risk with HRT. If risk with HRT is existed shift to alternatives to HRT.

Oophorectomy during hysterectomy for benign conditions be or not to be THAT IS THE QUESTION ?

1- If ovaries are pathologically affected → Removal. 2- If ovaries are healthy → controversy .

Some authors advise preservation of the ovaries during hysterectomy WHY? 1-Postmenopusal ovary still a functioning organ i.e main source of postmenopausal androgen that can be converted peripherally into estrogen. 2-There is evidence that retained ovaries work normally following hysterectomy. 3- Hysterectomy without Oophorectomy may reduce risk of ovarian cancer, why?

Some authors advise preservation of the ovaries during hysterectomy WHY? 4- Oophorectomy is associated with menopausal symptoms for which HRT is indicted . HRT is not without risk. 5- Oophorectomy does not eliminate the risk of cancer completely. 6- The prevalence of ovarian cancer is not so much to warrant Oophorectomy in every case ????

Some authors advise removal of the ovaries during hysterectomy WHY? 1-Minimize risk of cancer, ovary, tubes, and/ or breast. 2-No risk of postoperative : Benign Ovarian cysts. Residual Ovary Syndrome. Remnant Ovary Syndrome.

Some authors advise removal of the ovaries during hysterectomy WHY? 3- We can use alternatives to HRT {Minimal risk} 4-Development of different methods of patient Surveillance

Surveillance

Indications of Surveillance Women at risk [Risk factors of Ovarian &Breast cancer] refuse to be undergone Prophylactic Oophorectomy

Methods I } Proper screening for: A- Cancer Ovary. B- Cancer Breast. HOW?

II} Therapeutic measures provide protection: 1-Tamoxifen: ↓ incidence of breast cancer 62% in women with BRCA2 mutation , BUT, has no such protective effects in those with BRCA1mutation carrier.

II} Therapeutic measures provide protection: 2- Combined oral contraceptives: The risk of ovarian cancer :continues to ↓as years of use ↑, although there is little additional protection conferred by oral contraceptives beyond 6 years of use. The risk of breast cancer: No ↑.

II} Therapeutic measures provide protection: 3-Tubal ligation: In general population→↓ risk of ovarian cancer. In BRCA1, not in BRCA2 mutation carrier→↓ risk of ovarian cancer. 4- The protective benefits of higher parity, as well as longer duration of breastfeeding why? Suppress ovulation. ↓ Local E on breast.

II} Therapeutic measures provide protection: 5- Pregnancy: encouraged. Delayed childbearing → remove the protective benefits against ovarian &breast cancer.

CONCLUSION Prophylactic Oophorectomy is indicated in patient with risk factors for ovarian and/or cancer. Prophylactic Oophorectomy doesn't eliminate risk of cancer completely as it may be associated with primary peritoneal cancer that may be similar to ovarian cancer. Prophylactic Oophorectomy may be associated with risks and benefits.

CONCLUSION There is controversy about removal of healthy ovaries at time of hysterectomy in menopausal women. Women at risk of ovarian and breast cancer should be under surveillance if they refuse surgery.

Thank you E.MAIL::ahwalid2004@yahoo.com